menu
    • menu
    [{"orgOrder":0,"company":"LPOXY Therapeutics","sponsor":"5Horizons Ventures","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2025","type":"Series A Financing","leadProduct":"Oxygen","moa":"Cytochrome c oxidase subunit 1; NADPH oxidase 1","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"LPOXY Therapeutics","amount2":0.029999999999999999,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0.029999999999999999,"dosageForm":"Inhalation","sponsorNew":"LPOXY Therapeutics \/ 5Horizons Ventures","highestDevelopmentStatusID":"6","companyTruncated":"LPOXY Therapeutics \/ 5Horizons Ventures"}]

    Find Clinical Drug Pipeline Developments & Deals by LPOXY Therapeutics

    Menu

    LPOXY Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            LPOXY Therapeutics

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            LPOXY Therapeutics

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Oxygen

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase I

                            Sponsor : 5Horizons Ventures

                            Deal Size : $28.0 million

                            Deal Type : Series A Financing

                            DEALS_DEV arrow-down

                            LPOXY Initiates $28M Series A Financing to Fund STOP-Cdiff Pivotal Trial

                            Details : The proceeds will fund the registrational STOP-Cdiff (sidiprev trial on prevention of C. difficile infections) trial for Sidiprev, positioned to become the first prevention against C. difficile.

                            Product Name : Sidiprev

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            September 03, 2025

                            Lead Product(s) : Oxygen

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase I

                            Sponsor : 5Horizons Ventures

                            Deal Size : $28.0 million

                            Deal Type : Series A Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth